Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Synlogic names new CEO

This article was originally published in Scrip

Executive Summary

Synlogic, a biotechnology company focused on the development of therapeutic synthetic life, has named Dr Jose-Carlos (JC) Gutiérrez-Ramos president and CEO. Dr Gutiérrez-Ramos brings more than 20 years of experience in drug discovery and development leadership spanning the pharmaceutical and biotechnology industries as well as academia. He joins Synlogic from Pfizer where he was group senior vice-president and global head of BioTherapeutics R&D.  In that role, he held responsibility for more than 25 novel programs across the full spectrum of clinical development, re-launched efforts in rare disease discovery and development, and founded the Centers for Therapeutic Innovation.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts